You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Patient Derived Xenograft Models Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

The global Patient Derived Xenograft Models market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Patient Derived Xenograft Models by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Mice Models 
Rat Models

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Crown Bioscience Inc. (US) 
WuXi AppTec (China) 
Champions Oncology, Inc. (US) 
The Jackson Laboratory (US) 
ONCODESIGN (France) 
Charles River Laboratories International, Inc. (US) 
EPO Berlin-Buch GmBH (Germany) 
Shanghai LIDE Biotech Co., Ltd (China) 
Xentech (France) 
Horizon Discovery Group PLC (UK) 
Urolead (France) 
Explora BioLabs (US)

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Pharmaceutical & Biotechnology Companies 
Contract Research Organizations 
Academic & Research Institutions

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
Table of Contents
1 Industry Overview
1.1 Patient Derived Xenograft Models Industry
Figure Patient Derived Xenograft Models Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Patient Derived Xenograft Models
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Patient Derived Xenograft Models
1.2.2 Downstream
Table Application Segment of Patient Derived Xenograft Models
Table Global Patient Derived Xenograft Models Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Patient Derived Xenograft Models Market by Type
3.1 By Type
3.1.1 Mice Models 
Table Major Company List of Mice Models 
3.1.2 Rat Models
Table Major Company List of Rat Models
3.2 Market Size
Table Global Patient Derived Xenograft Models Market 2016-2020, by Type, in USD Million
Figure Global Patient Derived Xenograft Models Market Growth 2016-2020, by Type, in USD Million
Table Global Patient Derived Xenograft Models Market 2016-2020, by Type, in Volume
Figure Global Patient Derived Xenograft Models Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Patient Derived Xenograft Models Market Forecast 2021-2026, by Type, in USD Million
Table Global Patient Derived Xenograft Models Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Crown Bioscience Inc. (US)  (Company Profile, Sales Data etc.)
4.1.1 Crown Bioscience Inc. (US)  Profile
Table Crown Bioscience Inc. (US)  Overview List
4.1.2 Crown Bioscience Inc. (US)  Products & Services
4.1.3 Crown Bioscience Inc. (US)  Business Operation Conditions
Table Business Operation of Crown Bioscience Inc. (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 WuXi AppTec (China)  (Company Profile, Sales Data etc.)
4.2.1 WuXi AppTec (China)  Profile
Table WuXi AppTec (China)  Overview List
4.2.2 WuXi AppTec (China)  Products & Services
4.2.3 WuXi AppTec (China)  Business Operation Conditions
Table Business Operation of WuXi AppTec (China)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Champions Oncology, Inc. (US)  (Company Profile, Sales Data etc.)
4.3.1 Champions Oncology, Inc. (US)  Profile
Table Champions Oncology, Inc. (US)  Overview List
4.3.2 Champions Oncology, Inc. (US)  Products & Services
4.3.3 Champions Oncology, Inc. (US)  Business Operation Conditions
Table Business Operation of Champions Oncology, Inc. (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 The Jackson Laboratory (US)  (Company Profile, Sales Data etc.)
4.4.1 The Jackson Laboratory (US)  Profile
Table The Jackson Laboratory (US)  Overview List
4.4.2 The Jackson Laboratory (US)  Products & Services
4.4.3 The Jackson Laboratory (US)  Business Operation Conditions
Table Business Operation of The Jackson Laboratory (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 ONCODESIGN (France)  (Company Profile, Sales Data etc.)
4.5.1 ONCODESIGN (France)  Profile
Table ONCODESIGN (France)  Overview List
4.5.2 ONCODESIGN (France)  Products & Services
4.5.3 ONCODESIGN (France)  Business Operation Conditions
Table Business Operation of ONCODESIGN (France)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Charles River Laboratories International, Inc. (US)  (Company Profile, Sales Data etc.)
4.6.1 Charles River Laboratories International, Inc. (US)  Profile
Table Charles River Laboratories International, Inc. (US)  Overview List
4.6.2 Charles River Laboratories International, Inc. (US)  Products & Services
4.6.3 Charles River Laboratories International, Inc. (US)  Business Operation Conditions
Table Business Operation of Charles River Laboratories International, Inc. (US)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 EPO Berlin-Buch GmBH (Germany)  (Company Profile, Sales Data etc.)
4.7.1 EPO Berlin-Buch GmBH (Germany)  Profile
Table EPO Berlin-Buch GmBH (Germany)  Overview List
4.7.2 EPO Berlin-Buch GmBH (Germany)  Products & Services
4.7.3 EPO Berlin-Buch GmBH (Germany)  Business Operation Conditions
Table Business Operation of EPO Berlin-Buch GmBH (Germany)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Shanghai LIDE Biotech Co., Ltd (China)  (Company Profile, Sales Data etc.)
4.8.1 Shanghai LIDE Biotech Co., Ltd (China)  Profile
Table Shanghai LIDE Biotech Co., Ltd (China)  Overview List
4.8.2 Shanghai LIDE Biotech Co., Ltd (China)  Products & Services
4.8.3 Shanghai LIDE Biotech Co., Ltd (China)  Business Operation Conditions
Table Business Operation of Shanghai LIDE Biotech Co., Ltd (China)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Xentech (France)  (Company Profile, Sales Data etc.)
4.9.1 Xentech (France)  Profile
Table Xentech (France)  Overview List
4.9.2 Xentech (France)  Products & Services
4.9.3 Xentech (France)  Business Operation Conditions
Table Business Operation of Xentech (France)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Horizon Discovery Group PLC (UK)  (Company Profile, Sales Data etc.)
4.10.1 Horizon Discovery Group PLC (UK)  Profile
Table Horizon Discovery Group PLC (UK)  Overview List
4.10.2 Horizon Discovery Group PLC (UK)  Products & Services
4.10.3 Horizon Discovery Group PLC (UK)  Business Operation Conditions
Table Business Operation of Horizon Discovery Group PLC (UK)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Urolead (France)  (Company Profile, Sales Data etc.)
4.11.1 Urolead (France)  Profile
Table Urolead (France)  Overview List
4.11.2 Urolead (France)  Products & Services
4.11.3 Urolead (France)  Business Operation Conditions
Table Business Operation of Urolead (France)  (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Explora BioLabs (US) (Company Profile, Sales Data etc.)
4.12.1 Explora BioLabs (US) Profile
Table Explora BioLabs (US) Overview List
4.12.2 Explora BioLabs (US) Products & Services
4.12.3 Explora BioLabs (US) Business Operation Conditions
Table Business Operation of Explora BioLabs (US) (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Patient Derived Xenograft Models Sales Revenue 2016-2020, by Company, in USD Million
Table Global Patient Derived Xenograft Models Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Patient Derived Xenograft Models Sales Revenue Share in 2020, by Company, in USD Million
Table Global Patient Derived Xenograft Models Sales Volume 2016-2020, by Company, in Volume
Table Global Patient Derived Xenograft Models Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Patient Derived Xenograft Models Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Patient Derived Xenograft Models Market Concentration, in 2020
Figure Europe Patient Derived Xenograft Models Market Market Concentration, in 2020
Figure Asia-Pacific Patient Derived Xenograft Models MMarket Concentration, in 2020
Figure South America Patient Derived Xenograft Models Market Concentration, in 2020
Figure Middle East & Africa Patient Derived Xenograft Models Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Pharmaceutical & Biotechnology Companies 
Figure Patient Derived Xenograft Models Demand in Pharmaceutical & Biotechnology Companies , 2016-2020, in USD Million
Figure Patient Derived Xenograft Models Demand in Pharmaceutical & Biotechnology Companies , 2016-2020, in Volume
6.1.2 Demand in Contract Research Organizations 
Figure Patient Derived Xenograft Models Demand in Contract Research Organizations , 2016-2020, in USD Million
Figure Patient Derived Xenograft Models Demand in Contract Research Organizations , 2016-2020, in Volume
6.1.3 Demand in Academic & Research Institutions
Figure Patient Derived Xenograft Models Demand in Academic & Research Institutions, 2016-2020, in USD Million
Figure Patient Derived Xenograft Models Demand in Academic & Research Institutions, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Patient Derived Xenograft Models Demand Forecast 2021-2026, by Application, in USD Million
Figure Patient Derived Xenograft Models Market Growth 2021-2026, by Application, in USD Million
Figure Patient Derived Xenograft Models Market Share in 2026, by Application, in USD Million
Table Patient Derived Xenograft Models Demand Forecast 2021-2026, by Application, in Volume
Table Patient Derived Xenograft Models Market Growth 2021-2026, by Application, in Volume
Table Patient Derived Xenograft Models Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Patient Derived Xenograft Models Production 2016-2020, by Region, in USD Million
Table Patient Derived Xenograft Models Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Patient Derived Xenograft Models Market 2016-2020, by Region, in USD Million
Table Global Patient Derived Xenograft Models Market Share 2016-2020, by Region, in USD Million
Table Global Patient Derived Xenograft Models Market 2016-2020, by Region, in Volume
Table Global Patient Derived Xenograft Models Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million
Figure North America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million
Table North America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million
Figure Europe Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million
Table Europe Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million
Figure South America Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million
Table South America Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Patient Derived Xenograft Models Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Patient Derived Xenograft Models Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Patient Derived Xenograft Models Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Patient Derived Xenograft Models Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Patient Derived Xenograft Models Market Forecast 2021-2026, by Region, in USD Million
Table Patient Derived Xenograft Models Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 76